Triennial Review of the British Pharmacopoeia Commission - Call for Evidence

Closed 11 Jan 2015

Opened 1 Dec 2014


In recent years, the health and social care system in England has undergone substantial change. The Health and Social Care Act 2012 and the Care Act 2014 have devolved functions and powers away from the Department of Health to local and arm’s length bodies.

In this new system, the Department has the key stewardship and assurance function designed to ensure that the new system, and so the multiple new and reformed bodies within it, have the appropriate functions and are performing to a high standard.

To perform this stewardship function, the Department is putting in place Triennial Reviews of all of its Arm’s Length Bodies. This includes all Executive Non-Departmental Public Bodies (ENDPBs), Advisory Non-Departmental Public Bodies (ANDPBs), Executive Agencies and Special Health Authorities. The British Pharmacopoeia Commission (BPC), an ANDPB, is subject to review in 2014-15.

The programme of reviews uses the approach developed by the Cabinet Office as part of their work on public bodies reform.

Why We Are Consulting

As noted above, this review is part of a wider programme the Department of Health has developed as part of its stewardship and assurance function. The review will have two main stages:

  • The first is to provide a robust challenge of the continuing need for the BPC both in terms of the functions it performs, and the way in which these are delivered.
  • If it is agreed that the BPC should retain its current function and utilise the same delivery model, the second stage of the review will then consider its performance, capability and governance, as well as considering opportunities for efficiencies.

This Call for Evidence seeks views from respondents to assist its consideration of both of the above stages. The evidence is being gathered simultaneously for stage one and stage two in the interests of timeliness and value for money only, and is not an expression of pre-judgement as to the outcome of stage one on the part of the review.


  • GPs
  • Pharmacists
  • Regulatory body
  • Academic/ Professional institution
  • Royal Colleges
  • Members of the public
  • Suppliers


  • Public health